# Azilsartan medoxomil

## Edarbi 40mg

| TAH Drug Code      | [OEDA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OEDA)                                                                                                                                                                                                   |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension                                                                                                                                                                                                                                                           |
| Dosing             | HTN Initial: 20-40 mg QD; titrate up to maximum 80 mg QD                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity to the active substance or any excipients. Pregnant women throughout all stages of pregnancy. Concomitant use with Aliskiren-containing products in patients with diabetes or renal impairment (GFR < 60 mL/min/1.73 m2).                             |
| Adverse Effects    | Hypotension， orthostatic hypotension， Dizziness， fatigue， Diarrhea， nausea， Decreased hemoglobin， decreased hematocrit， decreased red blood cells， leukopenia (rare)， thrombocytopenia (rare)， Muscle spasm， weakness， Increased serum creatinine， Cough |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/azilsartan-drug-information)                                                                                                                                                                                              |

